Envista Holdings Corp Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
15.2%projected annual EPS growth
Analyst Coverage
14analysts covering
FY Revenue (est.)
$2.9Bnext fiscal year
FY EPS (est.)
$1.53next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 28 Oct 2026 |
Monitoring Framework
Key Performance Indicators
Core Revenue Growth Quarterly950.0%Target: 2% to 4%
Adjusted EBITDA Margin Quarterly1,400.0%Target: 7% to 13% adjusted EBITDA growth for FY 2026
Free Cash Flow Conversion AnnuallyTarget: Approximately 100%
Watch Items
- China Volume-Based Procurement (VBP) and Procurement ReformsTrigger: Further pricing pressure or volume declines in the Chinese dental marketAction: Adjust regional commercial strategies and optimize supply chain costs to protect margins.
- Tariff Costs and Supply Chain DisruptionsTrigger: Year-over-year tariff cost increases exceeding $11 millionAction: Accelerate supply chain relocation, pricing initiatives, and SG&A discipline.
- R&D and Innovation SpendingTrigger: R&D spending falling below double-digit year-over-year growth ratesAction: Reallocate capital to sustain product launches like Spark clear aligners and Nobel Biocare implants.
Research as of 19 Jun 2026